Published in Genes Dev on August 24, 2011
Finding the end: recruitment of telomerase to telomeres. Nat Rev Mol Cell Biol (2013) 1.73
The genetics of dyskeratosis congenita. Cancer Genet (2011) 1.50
Structure of active dimeric human telomerase. Nat Struct Mol Biol (2013) 1.23
A role for CTCF and cohesin in subtelomere chromatin organization, TERRA transcription, and telomere end protection. EMBO J (2012) 1.21
Mechanisms of functional promiscuity by HP1 proteins. Trends Cell Biol (2014) 1.09
Short telomeres: from dyskeratosis congenita to sporadic aplastic anemia and malignancy. Transl Res (2013) 1.08
Hoyeraal-Hreidarsson syndrome caused by a germline mutation in the TEL patch of the telomere protein TPP1. Genes Dev (2014) 1.07
Interplay between Epigenetics and Genetics in Cancer. Genomics Inform (2013) 1.03
Unraveling the pathogenesis of Hoyeraal-Hreidarsson syndrome, a complex telomere biology disorder. Br J Haematol (2015) 1.01
Molecular basis of telomere dysfunction in human genetic diseases. Nat Struct Mol Biol (2015) 0.97
Control of telomerase action at human telomeres. Nat Struct Mol Biol (2015) 0.95
Differential contribution of HP1 proteins to DNA end resection and homology-directed repair. Cell Cycle (2012) 0.94
HP1γ expression is elevated in prostate cancer and is superior to Gleason score as a predictor of biochemical recurrence after radical prostatectomy. BMC Cancer (2013) 0.94
TRF2-tethered TIN2 can mediate telomere protection by TPP1/POT1. Mol Cell Biol (2014) 0.93
One identity or more for telomeres? Front Oncol (2013) 0.91
A TIN2 dyskeratosis congenita mutation causes telomerase-independent telomere shortening in mice. Genes Dev (2014) 0.91
The molecular genetics of the telomere biology disorders. RNA Biol (2015) 0.91
Cockayne Syndrome group B protein interacts with TRF2 and regulates telomere length and stability. Nucleic Acids Res (2012) 0.89
Trypanosoma brucei TIF2 suppresses VSG switching by maintaining subtelomere integrity. Cell Res (2014) 0.88
The relationship between DNA methylation and telomere length in dyskeratosis congenita. Aging Cell (2011) 0.88
Telomeric G-quadruplexes are a substrate and site of localization for human telomerase. Nat Commun (2015) 0.88
Telomere-regulating genes and the telomere interactome in familial cancers. Mol Cancer Res (2014) 0.87
TIN2 stability is regulated by the E3 ligase Siah2. Mol Cell Biol (2011) 0.87
SA1 binds directly to DNA through its unique AT-hook to promote sister chromatid cohesion at telomeres. J Cell Sci (2013) 0.84
Persistent telomere cohesion triggers a prolonged anaphase. Mol Biol Cell (2013) 0.82
The Shelterin TIN2 Subunit Mediates Recruitment of Telomerase to Telomeres. PLoS Genet (2015) 0.82
Chromatin structure in telomere dynamics. Front Oncol (2013) 0.82
A role for sister telomere cohesion in telomere elongation by telomerase. Cell Cycle (2012) 0.81
Swi1Timeless Prevents Repeat Instability at Fission Yeast Telomeres. PLoS Genet (2016) 0.79
TRF1 ensures the centromeric function of Aurora-B and proper chromosome segregation. Mol Cell Biol (2014) 0.78
Loss of nucleolar histone chaperone NPM1 triggers rearrangement of heterochromatin and synergizes with a deficiency in DNA methyltransferase DNMT3A to drive ribosomal DNA transcription. J Biol Chem (2014) 0.78
Functional interplay between SA1 and TRF1 in telomeric DNA binding and DNA-DNA pairing. Nucleic Acids Res (2016) 0.78
Nucleosome compaction facilitates HP1γ binding to methylated H3K9. Nucleic Acids Res (2015) 0.77
Cell cycle regulated phosphorylation of the telomere-associated protein TIN2. PLoS One (2013) 0.76
A role for Separase in telomere protection. Nat Commun (2016) 0.76
TINF2 Gene Mutation in a Patient with Pulmonary Fibrosis. Case Rep Pulmonol (2016) 0.76
Independent Mechanisms Target SMCHD1 to Trimethylated Histone H3 Lysine 9-Modified Chromatin and the Inactive X Chromosome. Mol Cell Biol (2015) 0.75
The shelterin complex and hematopoiesis. J Clin Invest (2016) 0.75
Fundamental mechanisms of telomerase action in yeasts and mammals: understanding telomeres and telomerase in cancer cells. Open Biol (2017) 0.75
Osteoarthritis and telomere shortening. J Appl Genet (2014) 0.75
Guarding chromosomes from oxidative DNA damage to the very end. Acta Biochim Biophys Sin (Shanghai) (2016) 0.75
HP1 knockdown is associated with abnormal condensation of almost all chromatin types in a grasshopper (Eyprepocnemis plorans). Chromosome Res (2014) 0.75
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell (1997) 29.13
Methylation of histone H3 lysine 9 creates a binding site for HP1 proteins. Nature (2001) 19.67
Selective recognition of methylated lysine 9 on histone H3 by the HP1 chromo domain. Nature (2001) 19.54
How shelterin protects mammalian telomeres. Annu Rev Genet (2008) 11.20
TRF2 protects human telomeres from end-to-end fusions. Cell (1998) 10.13
The telomere terminal transferase of Tetrahymena is a ribonucleoprotein enzyme with two kinds of primer specificity. Cell (1987) 8.32
Control of telomere length by the human telomeric protein TRF1. Nature (1997) 7.62
Pot1, the putative telomere end-binding protein in fission yeast and humans. Science (2001) 6.95
Structure and variability of human chromosome ends. Mol Cell Biol (1990) 6.18
Identification of a new family of tissue-specific basic helix-loop-helix proteins with a two-hybrid system. Mol Cell Biol (1995) 5.71
Molecular architecture of SMC proteins and the yeast cohesin complex. Mol Cell (2002) 5.36
The POT1-TPP1 telomere complex is a telomerase processivity factor. Nature (2007) 5.08
Telomerase activity in human germline and embryonic tissues and cells. Dev Genet (1996) 5.00
TIN2, a new regulator of telomere length in human cells. Nat Genet (1999) 4.66
Telomeres and telomerase in cancer. Carcinogenesis (2009) 4.28
TPP1 is a homologue of ciliate TEBP-beta and interacts with POT1 to recruit telomerase. Nature (2007) 4.23
TINF2, a component of the shelterin telomere protection complex, is mutated in dyskeratosis congenita. Am J Hum Genet (2008) 4.12
Characterization of vertebrate cohesin complexes and their regulation in prophase. J Cell Biol (2000) 3.70
Epigenetic regulation of telomere length in mammalian cells by the Suv39h1 and Suv39h2 histone methyltransferases. Nat Genet (2003) 3.64
Cohesion between sister chromatids must be established during DNA replication. Curr Biol (1998) 3.62
The cohesin ring concatenates sister DNA molecules. Nature (2008) 3.58
PTOP interacts with POT1 and regulates its localization to telomeres. Nat Cell Biol (2004) 3.33
POT1-interacting protein PIP1: a telomere length regulator that recruits POT1 to the TIN2/TRF1 complex. Genes Dev (2004) 3.25
Resolution of sister telomere association is required for progression through mitosis. Science (2004) 3.13
Condensin and cohesin display different arm conformations with characteristic hinge angles. J Cell Biol (2002) 3.09
The structure of mouse HP1 suggests a unique mode of single peptide recognition by the shadow chromo domain dimer. EMBO J (2000) 3.04
TINF2 mutations result in very short telomeres: analysis of a large cohort of patients with dyskeratosis congenita and related bone marrow failure syndromes. Blood (2008) 3.02
Identification and characterization of SA/Scc3p subunits in the Xenopus and human cohesin complexes. J Cell Biol (2000) 2.91
Localization and phosphorylation of HP1 proteins during the cell cycle in mammalian cells. Chromosoma (1999) 2.79
Telomere extension occurs at most chromosome ends and is uncoupled from fill-in in human cancer cells. Cell (2009) 2.76
Telosome, a mammalian telomere-associated complex formed by multiple telomeric proteins. J Biol Chem (2004) 2.76
Telomerase RNA mutations in Saccharomyces cerevisiae alter telomerase action and reveal nonprocessivity in vivo and in vitro. Genes Dev (1997) 2.73
TIN2 mediates functions of TRF2 at human telomeres. J Biol Chem (2004) 2.52
The HP1 chromo shadow domain binds a consensus peptide pentamer. Curr Biol (2000) 2.47
Zscan4 regulates telomere elongation and genomic stability in ES cells. Nature (2010) 2.46
A dynamic molecular link between the telomere length regulator TRF1 and the chromosome end protector TRF2. Curr Biol (2004) 2.45
TIN2-tethered TPP1 recruits human telomerase to telomeres in vivo. Mol Cell Biol (2010) 2.39
Suv39H1 and HP1gamma are responsible for chromatin-mediated HIV-1 transcriptional silencing and post-integration latency. EMBO J (2007) 2.37
Functionally interacting telomerase RNAs in the yeast telomerase complex. Genes Dev (1997) 2.37
TIN2 binds TRF1 and TRF2 simultaneously and stabilizes the TRF2 complex on telomeres. J Biol Chem (2004) 2.36
Targeting of cohesin by transcriptionally silent chromatin. Genes Dev (2005) 2.28
Role of the RB1 family in stabilizing histone methylation at constitutive heterochromatin. Nat Cell Biol (2005) 2.27
Cell cycle-regulated trafficking of human telomerase to telomeres. Mol Biol Cell (2005) 2.26
Role for the related poly(ADP-Ribose) polymerases tankyrase 1 and 2 at human telomeres. Mol Cell Biol (2002) 2.22
The Heterochromatin Protein 1 family. Genome Biol (2006) 2.05
Telomere lengthening early in development. Nat Cell Biol (2007) 2.02
Human telomerase contains two cooperating telomerase RNA molecules. EMBO J (2001) 1.99
Disruption of telomerase trafficking by TCAB1 mutation causes dyskeratosis congenita. Genes Dev (2011) 1.98
Cell cycle-dependent recruitment of telomerase RNA and Cajal bodies to human telomeres. Mol Biol Cell (2005) 1.93
X-linked dyskeratosis congenita is predominantly caused by missense mutations in the DKC1 gene. Am J Hum Genet (1999) 1.80
Three novel truncating TINF2 mutations causing severe dyskeratosis congenita in early childhood. Clin Genet (2011) 1.74
HP1: a functionally multifaceted protein. Curr Opin Genet Dev (2008) 1.72
A handcuff model for the cohesin complex. J Cell Biol (2008) 1.64
CST meets shelterin to keep telomeres in check. Mol Cell (2010) 1.63
A novel form of the telomere-associated protein TIN2 localizes to the nuclear matrix. Cell Cycle (2009) 1.58
Normal human telomeres are not late replicating. Exp Cell Res (1999) 1.57
A 'higher order' of telomere regulation: telomere heterochromatin and telomeric RNAs. EMBO J (2009) 1.56
Telomere length dynamics in telomerase-positive immortal human cell populations. Exp Cell Res (1998) 1.47
Protein requirements for sister telomere association in human cells. EMBO J (2007) 1.45
Differential regulation of telomere and centromere cohesion by the Scc3 homologues SA1 and SA2, respectively, in human cells. J Cell Biol (2009) 1.43
Dyskeratosis congenita. FEBS Lett (2010) 1.36
Processive and distributive extension of human telomeres by telomerase under homeostatic and nonequilibrium conditions. Mol Cell (2011) 1.26
Sister acts: coordinating DNA replication and cohesion establishment. Genes Dev (2010) 1.24
Telomere length measurement can distinguish pathogenic from non-pathogenic variants in the shelterin component, TIN2. Clin Genet (2011) 1.08
TIN2 protein dyskeratosis congenita missense mutants are defective in association with telomerase. J Biol Chem (2011) 1.04
X-linked dyskeratosis congenita: restrictive pulmonary disease and a novel mutation. Thorax (2001) 0.99
Osteosarcoma incidence and survival rates from 1973 to 2004: data from the Surveillance, Epidemiology, and End Results Program. Cancer (2009) 6.00
A genome-wide association study of lung cancer identifies a region of chromosome 5p15 associated with risk for adenocarcinoma. Am J Hum Genet (2009) 5.62
Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nat Genet (2013) 4.35
Cancer in dyskeratosis congenita. Blood (2009) 4.28
Very short telomere length by flow fluorescence in situ hybridization identifies patients with dyskeratosis congenita. Blood (2007) 3.86
Detectable clonal mosaicism and its relationship to aging and cancer. Nat Genet (2012) 3.69
The association of telomere length and cancer: a meta-analysis. Cancer Epidemiol Biomarkers Prev (2011) 3.29
Resolution of sister telomere association is required for progression through mitosis. Science (2004) 3.13
Malignancies and survival patterns in the National Cancer Institute inherited bone marrow failure syndromes cohort study. Br J Haematol (2010) 3.09
A dynamic molecular link between the telomere length regulator TRF1 and the chromosome end protector TRF2. Curr Biol (2004) 2.45
Architectural dynamics of the meiotic spindle revealed by single-fluorophore imaging. Nat Cell Biol (2007) 2.40
TRF1 is degraded by ubiquitin-mediated proteolysis after release from telomeres. Genes Dev (2003) 2.27
Role for the related poly(ADP-Ribose) polymerases tankyrase 1 and 2 at human telomeres. Mol Cell Biol (2002) 2.22
The association between leukocyte telomere length and cigarette smoking, dietary and physical variables, and risk of prostate cancer. Aging Cell (2009) 2.22
A randomized, placebo-controlled, double-masked clinical trial of etanercept for the treatment of uveitis associated with juvenile idiopathic arthritis. Arthritis Rheum (2005) 2.20
Effect of antibiotic prescribing on antibiotic resistance in individual children in primary care: prospective cohort study. BMJ (2007) 2.19
Tankyrase function at telomeres, spindle poles, and beyond. Biochimie (2007) 2.12
Germline mutations of regulator of telomere elongation helicase 1, RTEL1, in Dyskeratosis congenita. Hum Genet (2013) 2.10
Poly(ADP-ribose) polymerase 3 (PARP3), a newcomer in cellular response to DNA damage and mitotic progression. Proc Natl Acad Sci U S A (2011) 2.10
How long does it take for epilepsy to become intractable? A prospective investigation. Ann Neurol (2006) 2.09
Telomere shortening and loss of self-renewal in dyskeratosis congenita induced pluripotent stem cells. Nature (2011) 2.03
Disruption of telomerase trafficking by TCAB1 mutation causes dyskeratosis congenita. Genes Dev (2011) 1.98
International osteosarcoma incidence patterns in children and adolescents, middle ages and elderly persons. Int J Cancer (2009) 1.91
Tankyrase 1 and tankyrase 2 are essential but redundant for mouse embryonic development. PLoS One (2008) 1.86
mRNA decay factor AUF1 maintains normal aging, telomere maintenance, and suppression of senescence by activation of telomerase transcription. Mol Cell (2012) 1.86
The genetics and clinical manifestations of telomere biology disorders. Genet Med (2010) 1.83
Telomere length is associated with disease severity and declines with age in dyskeratosis congenita. Haematologica (2011) 1.71
Ataxia telangiectasia mutated activation by transcription- and topoisomerase I-induced DNA double-strand breaks. EMBO Rep (2009) 1.69
Integrating medical management with diabetes self-management training: a randomized control trial of the Diabetes Outpatient Intensive Treatment program. Diabetes Care (2003) 1.68
Telomere length in blood, buccal cells, and fibroblasts from patients with inherited bone marrow failure syndromes. Aging (Albany NY) (2010) 1.62
The telomeric poly(ADP-ribose) polymerase, tankyrase 1, contains multiple binding sites for telomeric repeat binding factor 1 (TRF1) and a novel acceptor, 182-kDa tankyrase-binding protein (TAB182). J Biol Chem (2002) 1.57
Trauma resuscitation errors and computer-assisted decision support. Arch Surg (2011) 1.57
Distinct faces of the Ku heterodimer mediate DNA repair and telomeric functions. Nat Struct Mol Biol (2007) 1.55
Using transcriptome sequencing to identify mechanisms of drug action and resistance. Nat Chem Biol (2012) 1.53
The association of telomere length and genetic variation in telomere biology genes. Hum Mutat (2010) 1.53
NuMA is a major acceptor of poly(ADP-ribosyl)ation by tankyrase 1 in mitosis. Biochem J (2005) 1.53
Telomere length in peripheral leukocyte DNA and gastric cancer risk. Cancer Epidemiol Biomarkers Prev (2009) 1.48
Ocular and orbital manifestations of the inherited bone marrow failure syndromes: Fanconi anemia and dyskeratosis congenita. Ophthalmology (2009) 1.47
Protein requirements for sister telomere association in human cells. EMBO J (2007) 1.45
Tankyrase 2 poly(ADP-ribose) polymerase domain-deleted mice exhibit growth defects but have normal telomere length and capping. Mol Cell Biol (2006) 1.45
Differential regulation of telomere and centromere cohesion by the Scc3 homologues SA1 and SA2, respectively, in human cells. J Cell Biol (2009) 1.43
Increased nerve and blood vessel ingrowth associated with proteoglycan depletion in an ovine anular lesion model of experimental disc degeneration. Spine (Phila Pa 1976) (2002) 1.39
Epidemiologic evidence for a role of telomere dysfunction in cancer etiology. Mutat Res (2011) 1.37
Dyskeratosis congenita as a disorder of telomere maintenance. Mutat Res (2011) 1.35
Leukocyte telomere length in a population-based case-control study of ovarian cancer: a pilot study. Cancer Causes Control (2009) 1.32
Variants in the VCAM1 gene and risk for symptomatic stroke in sickle cell disease. Blood (2002) 1.27
Updates on the biology and management of dyskeratosis congenita and related telomere biology disorders. Expert Rev Hematol (2013) 1.20
Consequences of mutations in the non-coding RMRP RNA in cartilage-hair hypoplasia. Hum Mol Genet (2005) 1.19
Genome-wide association study of relative telomere length. PLoS One (2011) 1.16
Segregating YKU80 and TLC1 alleles underlying natural variation in telomere properties in wild yeast. PLoS Genet (2009) 1.14
Proposal for the clinical detection and management of patients and their family members with familial myelodysplastic syndrome/acute leukemia predisposition syndromes. Leuk Lymphoma (2012) 1.13
Lung transplantation for pulmonary fibrosis in dyskeratosis congenita: Case Report and systematic literature review. BMC Blood Disord (2011) 1.12
LINE-1 methylation is inherited in familial testicular cancer kindreds. BMC Med Genet (2010) 1.11
Sister telomeres rendered dysfunctional by persistent cohesion are fused by NHEJ. J Cell Biol (2009) 1.11
Poly(ADP-ribose) polymerase inhibitor ABT-888 potentiates the cytotoxic activity of temozolomide in leukemia cells: influence of mismatch repair status and O6-methylguanine-DNA methyltransferase activity. Mol Cancer Ther (2009) 1.11
Mutations in the reverse transcriptase component of telomerase (TERT) in patients with bone marrow failure. Blood Cells Mol Dis (2006) 1.09
Squamous cell carcinomas in patients with Fanconi anemia and dyskeratosis congenita: a search for human papillomavirus. Int J Cancer (2013) 1.08
Comparative spatial and temporal localisation of perlecan, aggrecan and type I, II and IV collagen in the ovine meniscus: an ageing study. Histochem Cell Biol (2005) 1.08
Short telomeres: from dyskeratosis congenita to sporadic aplastic anemia and malignancy. Transl Res (2013) 1.08
Telomere length and the risk of cutaneous malignant melanoma in melanoma-prone families with and without CDKN2A mutations. PLoS One (2013) 1.07
Outcomes of allogeneic hematopoietic cell transplantation in patients with dyskeratosis congenita. Biol Blood Marrow Transplant (2013) 1.07
Burns caused by steam inhalation for respiratory tract infections in children. BMJ (2004) 1.07
Height at diagnosis and birth-weight as risk factors for osteosarcoma. Cancer Causes Control (2011) 1.07
Genomic characterization of the inherited bone marrow failure syndromes. Semin Hematol (2013) 1.07
A recessive founder mutation in regulator of telomere elongation helicase 1, RTEL1, underlies severe immunodeficiency and features of Hoyeraal Hreidarsson syndrome. PLoS Genet (2013) 1.05
Telomere biology in hematopoiesis and stem cell transplantation. Blood Rev (2011) 1.05
The long and short of telomeres and cancer association studies. J Natl Cancer Inst (2013) 1.04
Li-Fraumeni syndrome: report of a clinical research workshop and creation of a research consortium. Cancer Genet (2012) 1.04
Spatial and temporal localization of transforming growth factor-beta, fibroblast growth factor-2, and osteonectin, and identification of cells expressing alpha-smooth muscle actin in the injured anulus fibrosus: implications for extracellular matrix repair. Spine (Phila Pa 1976) (2002) 1.03
Infantile fibrosarcoma: clinical and histologic responses to cytotoxic chemotherapy. Pediatr Blood Cancer (2009) 1.01
Telomere length and variation in telomere biology genes in individuals with osteosarcoma. Int J Mol Epidemiol Genet (2010) 1.01
Erythrocyte adenosine deaminase: diagnostic value for Diamond-Blackfan anaemia. Br J Haematol (2012) 1.01
Randomized controlled trial to assess the short-term effectiveness of tailored web- and text-based facilitation of smoking cessation in primary care (iQuit in practice). Addiction (2014) 1.01
The structure, location, and function of perlecan, a prominent pericellular proteoglycan of fetal, postnatal, and mature hyaline cartilages. J Biol Chem (2006) 1.01
H/ACA small RNA dysfunctions in disease reveal key roles for noncoding RNA modifications in hematopoietic stem cell differentiation. Cell Rep (2013) 1.01
A comprehensive candidate gene approach identifies genetic variation associated with osteosarcoma. BMC Cancer (2011) 1.00
Functional subdomain in the ankyrin domain of tankyrase 1 required for poly(ADP-ribosyl)ation of TRF1 and telomere elongation. Mol Cell Biol (2004) 0.97
The role of phosphatidylinositol 3-kinase, rho family GTPases, and STAT3 in Ros-induced cell transformation. J Biol Chem (2002) 0.96
Activated protein C prevents inflammation yet stimulates angiogenesis to promote cutaneous wound healing. Wound Repair Regen (2005) 0.95
Ku must load directly onto the chromosome end in order to mediate its telomeric functions. PLoS Genet (2011) 0.94
Adult genital surgery for intersex: a solution to what problem? J Health Psychol (2005) 0.94
Clinical, histopathologic, and genetic features of pediatric primary myelofibrosis--an entity different from adults. Am J Hematol (2012) 0.94
Telomere length and risk of glioma. Cancer Epidemiol (2013) 0.94
Intravenous immunoglobulin utilization in the Canadian Atlantic provinces: a report of the Atlantic Collaborative Intravenous Immune Globulin Utilization Working Group. Transfusion (2007) 0.92
Genetic variation at chromosome 8q24 in osteosarcoma cases and controls. Carcinogenesis (2010) 0.92
Tankyrase 1 regulates centrosome function by controlling CPAP stability. EMBO Rep (2012) 0.92
The experience of motherhood in women with severe and enduring mental illness. Soc Psychiatry Psychiatr Epidemiol (2002) 0.91
Oral L-arginine and vitamins E and C improve endothelial function in women with type 2 diabetes. Vasc Med (2003) 0.91
Impact of declining fertility rates in Canada on donor options in blood and marrow transplantation. Biol Blood Marrow Transplant (2009) 0.90
Vaccination with F1-V fusion protein protects black-footed ferrets (Mustela nigripes) against plague upon oral challenge with Yersinia pestis. J Wildl Dis (2008) 0.89
Response to androgen therapy in patients with dyskeratosis congenita. Br J Haematol (2014) 0.89
The relationship between DNA methylation and telomere length in dyskeratosis congenita. Aging Cell (2011) 0.88
Study protocol for iQuit in Practice: a randomised controlled trial to assess the feasibility, acceptability and effectiveness of tailored web- and text-based facilitation of smoking cessation in primary care. BMC Public Health (2013) 0.88
Perlecan, the multidomain heparan sulfate proteoglycan of basement membranes, is also a prominent component of the cartilaginous primordia in the developing human fetal spine. J Histochem Cytochem (2003) 0.88
A review of factors influencing the banking of collected umbilical cord blood units. Stem Cells Int (2013) 0.87
Predictors of intubation success and therapeutic value of paramedic airway management in a large, urban EMS system. Prehosp Emerg Care (2006) 0.87
TIN2 stability is regulated by the E3 ligase Siah2. Mol Cell Biol (2011) 0.87
On the interplay of telomeres, nevi and the risk of melanoma. PLoS One (2012) 0.87
Stability of whole blood at -70 degrees C for measurement of hemoglobin A(1c) in healthy individuals. Clin Chem (2004) 0.87